SlideShare una empresa de Scribd logo
1 de 50
Descargar para leer sin conexión
ATRIAL SEPTAL DEFECT
(ASD)
Presenter
Dr. Maimuna Sayeed
Resident (Phase A)
Paediatric Gastroenterology & Nutrition
Introduction
Atrial septal defect (ASD) is
an abnormal communication
between the atria due to a
defect in the interatrial
septum.
Incidence
• ASDs constitute 8% to 10% of congenital heart defects in
children.
• The recent incidence of ASDs has been estimated to be 100
per 100,000 live births.
• The female:male ratio for secundum ASDs is 2:1, but for
the sinus venosus ASDs it is 1:1 .
Moss and Adams’ Heart disease in infants, children and adolescents, 9th edition
Incidence
About 30% to 50% of children with congenital heart defects
have an ASD as part of the cardiac defect.
Park’s Pediatric Cardiology for Practitioners, 6th edition
Epidemiology
The majority of cases of ASD are sporadic.
Autosomal dominant inheritance does occur as part of the
• Holt-Oram syndrome (hypoplastic or absent thumbs,
radii, triphalangism, phocomelia, 1st-degree heart block,
ASD) or in
• families with secundum ASD and heart block.
Nelson Textbook of Pediatrics, 20th edition
Formation of the
Interatrial septum
Types of ASD
1. Secundum ASD (75%)
2. Ostium primum ASD
(20%)
3. Sinus venosus ASD (5%)
4. Coronary sinus ASD (<1%)
Moss and Adams’ Heart disease in infants, children
and adolescents, 9th edition
Secundum ASDs
Location:
• This defect is present at
the site of fossa ovalis.
• Secundum ASDs may be
single or multiple
(fenestrated atrial
septum).
Secundum ASDs (cont)
Associations:
• Partial anomalous pulmonary venous return
• Pulmonary valvular stenosis
• VSD
• Pulmonary artery branch stenosis
• Persistent left superior vena cava
• Mitral valve prolapse and insufficiency
• Holt-Oram syndrome
Ostium primum ASD
Location:
• In the lower portion of the
atrial septum and overlies
the mitral and tricuspid
valves.
Ostium primum ASD (cont)
Associations:
Isolated ostium primum ASD occurs in about 15% of all ASDs.
Other defects include-
• Ostium primum defects with clefts in the anterior mitral
and septal tricuspid valve leaflets and
• Small ventricular septal defects.
Sinus venosus ASD
Location:
• It is most commonly
located at the entry of the
SVC into the RA (superior
vena caval type) and
• rarely at the entry of the
IVC into the RA (inferior
vena caval type).
Sinus venosus ASD (cont)
Associations:
• The superior vena caval type is very commonly associated
with anomalous drainage of the right upper pulmonary
vein (into the RA), and
• The inferior vena caval type is often associated with
anomalous drainage of the right lung into the IVC (“scimitar
syndrome”)
Coronary sinus ASD
Location:
• There is a defect in the roof of the coronary sinus, resulting in
direct communication with the left atrium.
Types:
• Complete unroofing of the CS
• Partial unroofing of the CS
Associations:
• Commonly with a persistent left SVC.
Pathophysiology of ASD
The degree of left to right shunting is dependent on:
• the size of the defect
• the relative compliance of the right ventricle and left
ventricle and
• the relative vascular resistance in the pulmonary and
systemic circulations.
Pathophysiology (cont)
In moderate-to-large defects, a considerable shunt of
oxygenated blood flows from the left to the right atrium
↓
Volume overload and dilation of the right atrium and ventricle
↓
The tricuspid and pulmonary annuli may dilate and become
incompetent
↓
Increased flow into the lungs
↓
Pulmonary arteries, capillaries & the veins are dilated
Pathophysiology (cont)
Pulmonary arteries, capillaries & the veins are dilated
↓
Flow-related pulmonary artery hypertension
↓
Medial hypertrophy of pulmonary arteries and
muscularization of the arterioles resulting in pulmonary
vascular obstructive disease
↓
Reversal of the shunt
↓
Eisenmenger syndrome
Clinical Presentation
History
 Asymptomatic
 Infants
• features of pulmonary overcirculation
• recurrent respiratory infections
• failure to thrive
 Older children
• mild fatigue
• dyspnea that may worsen with age
Physical Examination
Examination of precordium
Inspection:
Left precordial bulge.
Palpation:
Prominent right ventricular impulse felt along the
lower left sternal border and the subcostal area.
Physical Examination (cont)
Auscultation:
• Wide, fixed splitting of the second heart sound (S2).
• A systolic ejection murmur best heard at the left
upper sternal border.
• A short, rumbling mid-diastolic murmur is often
audible at the lower left sternal border.
Diagnostic Evaluation
Investigations
• Chest X-RAY
• ECG
• Echocardiography
• Cardiac catheterization (occasionally)
Chest X-Ray
A small shunt across the ASD
• normal-appearing CXR
Patients with significant shunts
• Cardiomegaly, due to right
atrial and right ventricular
enlargement, and
• Increased pulmonary
vascular markings extending
to the periphery.
• A prominent pulmonary
artery (PA) segment.
Electrocardiogram
A small left-to-right shunt and no right atrial or ventricular
dilation, the ECG is normal.
Secundum ASD
A significant left-to-right shunt
• Right axis deviation
• Right ventricular hypertrophy
• rsR′ pattern in V1
Electrocardiogram (cont)
Ostium Primum ASD
• Left axis deviation
Echocardiography
Two-dimensional echo study is
diagnostic.
It shows
• the position as well as the
size of the defect.
• the enlarged right atrium,
right ventricle, and
pulmonary arteries.
• associated anomalies such as
pulmonary stenosis, mitral
valve prolapse, and
anomalous pulmonary
venous return.
Echocardiography (cont)
Color Doppler can visualize
the shunt across the ASD.
• A qualitative assessment
of the shunt across the
ASD is done by direct
visualization of the shunt
and its effect on the right-
sided cardiac chambers.
• A quantitative assessment
of the pulmonary to
systemic blood flow ratio
(Qp: Qs) also can be made.
Echocardiography (cont)
Pulsed Doppler examination reveals a characteristic flow
pattern with the maximum left-to-right shunt occurring in
diastole.
Echocardiography (cont)
Transesophageal
echocardiography (TEE)
• may be used as an
alternative for older
children and adolescents,
especially in those who
are overweight.
• used to detect a sinus
venosus ASD.
• is a monitoring adjunct
for operative and per-
cutaneous closure of ASD.
Echocardiography (cont)
Three-Dimensional
Echocardiography
• allows better morphologic
delineation of the ASD and
its surrounding structures.
• used for guiding device
closure during the
procedure.
Cardiac Catheterization
Indicated
• If pulmonary vascular disease is suspected.
• Diagnosing associated lesions such as
partial anomalous pulmonary venous return or
mitral stenosis.
• Direct measurement of intracardiac and pulmonary artery
pressure can be performed.
• Pulmonary vascular resistance can be calculated.
Management
Medical
1. Exercise restriction is unnecessary.
2. Asymptomatic infant and children are followed up at
yearly interval until surgery is recommended prior to
school entry.
3. Symptomatic, anti-congestive therapy with diuretics may
be indicated until closure is accomplished.
Management (cont)
Closure of an ASD is indicated if there is a large shunt.
Indicators of a large shunt include
• Qp:Qs ≥ 1.5.
• A diastolic flow rumble in the tricuspid area,
• ECG evidence of right ventricular hypertrophy,
• Chest x-ray evidence of cardiomegaly or increased
pulmonary vascular markings, or
• Echocardiographic evidence of right ventricular
enlargement and/or paradoxical septal motion.
Nonsurgical Closure
• Several closure devices that can be delivered through
cardiac catheters have been shown to be safe and
efficacious for secundum ASD closure.
• Currently there is no transcatheter devices designed for
closer of sinus venosus, primum or coronary sinus ASD.
Nonsurgical Closure
Devices available for clinical use:
A. Amplatzer septal occlude
B. Gore Helix septal occlude
C. CardioSEAL device
D. BioSTAR device
Nonsurgical Closure
Nonsurgical Closure
Indications
• Secundum ASD, measuring 5 mm or more in diameter
(but less than 32 mm).
• A significant left-to-right shunt with clinical evidence of
right ventricular volume overload (i.e., Qp/Qs ratio of
1.5:1 or greater or RV enlargement).
• There must be enough rim (4 mm) of septal tissue
around the defect for appropriate placement of the
device.
Nonsurgical Closure
Advantages
• Complete avoidance of cardiopulmonary bypass.
• Avoidance of pain and residual thoracotomy scars.
• A less than 24-hour hospital stay, and rapid recovery.
Nonsurgical Closure
Post-device closure follow-up:
The patients are administered aspirin 5 mg/kg/day for 6
months.
Post procedure echo studies check for
• a residual atrial shunt and
• unobstructed flow of pulmonary veins, coronary sinus,
and venae cavae and
• proper function of the mitral and tricuspid valves.
Surgical Closure
Indications and Timing
• A left-to-right shunt with a pulmonary-to-systemic blood
flow ratio ( Qp/ Qs) of ≥1.5:1 only if device closure is not
considered appropriate.
• If CHF does not respond to medical management, surgery
is performed during infancy, again if device closure is
considered inappropriate.
• If oxygen and other medical therapy are needed for infants
with associated bronchopulmonary dysplasia and the
device closure is not considered appropriate, surgery is
performed during infancy.
• ASD with other associations
Surgical Closure
Surgical Closure
Surgical Closure
Complications:
• Cerebrovascular accident and
• Postoperative arrhythmias
Surgical Closure
Postoperative Follow-up
• Cardiomegaly on x-ray film and enlarged RV dimension on
echo as well as the wide splitting of the S2 may persist for 1
or 2 years postoperatively. The ECG typically demonstrates
RBBB (or RV conduction disturbance).
• Atrial or nodal arrhythmias occur in 7% to 20% of
postoperative patients. Occasionally, sick sinus syndrome,
which occurs especially after the repair of a sinus venosus
defect, may require antiarrhythmic drugs, pacemaker
therapy, or both.
• Rarely, patients with residual shunt may be administered
aspirin to prevent paradoxical embolization.
Natural History of ASDs
• In patients with an ASD less than 3 mm in size diagnosed
before 3 months of age, spontaneous closure occurs in
100% of patients at 1½ years of age.
• Spontaneous closure occurs more than 80% in patients
with defects between 3 and 8 mm before 1½ years of age.
• An ASD with a diameter greater than 8 mm rarely closes
spontaneously.
Natural History of ASDs
• Most children with an ASD remain active and
asymptomatic. Rarely, congestive heart failure (CHF) can
develop in infancy.
• If a large defect is untreated, CHF and pulmonary
hypertension develop in adults who are in their 20s and
30s.
• With or without surgery, atrial arrhythmias (flutter or
fibrillation) may occur in adults.
• Infective endocarditis does not occur in patients with
isolated ASDs.
• Cerebrovascular accident, resulting from paradoxical
embolization through an ASD, is a rare complication.
Thank you

Más contenido relacionado

Similar a atrialseptaldefect-170725142325.pdf

Acyanotic congenital heart diseases
Acyanotic congenital heart diseasesAcyanotic congenital heart diseases
Acyanotic congenital heart diseasesDr Saikiran Reddy
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.pptDrAliAlsaady1
 
Neonatal heart diseases
Neonatal heart diseasesNeonatal heart diseases
Neonatal heart diseasesDrisya Nidhin
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart diseaseEngidaw Ambelu
 
valvular heart disease LECT.pdf
valvular heart disease LECT.pdfvalvular heart disease LECT.pdf
valvular heart disease LECT.pdfisrashiekh
 
Congenital heart disease
Congenital heart disease Congenital heart disease
Congenital heart disease mesfin mamuye
 
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRAtrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRDR NIKUNJ SHEKHADA
 
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptxCONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptxErhardRutakulemberwa
 
Atrial septal defects 16 3-15
Atrial septal defects 16 3-15Atrial septal defects 16 3-15
Atrial septal defects 16 3-15Dr. Harshil Joshi
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.pptSalam467227
 
Patent Ductus Arteriosus (PDA)
Patent Ductus Arteriosus (PDA)Patent Ductus Arteriosus (PDA)
Patent Ductus Arteriosus (PDA)Dr.Sayeedur Rumi
 
Acyanoticcongenitalheartdisease 150417031927-conversion-gate01
Acyanoticcongenitalheartdisease 150417031927-conversion-gate01Acyanoticcongenitalheartdisease 150417031927-conversion-gate01
Acyanoticcongenitalheartdisease 150417031927-conversion-gate01Manju Mulamootll Abraham
 
Congenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - RivinCongenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - RivinRivindu Wickramanayake
 
Timing of Interventions in Acyanotic CHD
Timing of Interventions in Acyanotic CHDTiming of Interventions in Acyanotic CHD
Timing of Interventions in Acyanotic CHDRavi Kumar
 

Similar a atrialseptaldefect-170725142325.pdf (20)

Acyanotic congenital heart diseases
Acyanotic congenital heart diseasesAcyanotic congenital heart diseases
Acyanotic congenital heart diseases
 
congenital heart disease
congenital heart diseasecongenital heart disease
congenital heart disease
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
 
Congenital Heart Diseases
Congenital Heart DiseasesCongenital Heart Diseases
Congenital Heart Diseases
 
Neonatal heart diseases
Neonatal heart diseasesNeonatal heart diseases
Neonatal heart diseases
 
Congenital heart disease
Congenital heart diseaseCongenital heart disease
Congenital heart disease
 
Asd new
Asd newAsd new
Asd new
 
valvular heart disease LECT.pdf
valvular heart disease LECT.pdfvalvular heart disease LECT.pdf
valvular heart disease LECT.pdf
 
Congenital heart disease
Congenital heart disease Congenital heart disease
Congenital heart disease
 
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRAtrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
 
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptxCONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
CONGENITAL HEART DISEASE LECTURE NOTES MD3.pptx
 
Tricuspid atresia
Tricuspid atresiaTricuspid atresia
Tricuspid atresia
 
Atrial septal defects 16 3-15
Atrial septal defects 16 3-15Atrial septal defects 16 3-15
Atrial septal defects 16 3-15
 
Congenital Heart Disease.ppt
Congenital Heart Disease.pptCongenital Heart Disease.ppt
Congenital Heart Disease.ppt
 
Patent Ductus Arteriosus (PDA)
Patent Ductus Arteriosus (PDA)Patent Ductus Arteriosus (PDA)
Patent Ductus Arteriosus (PDA)
 
Congmal (1)
Congmal (1)Congmal (1)
Congmal (1)
 
Acyanoticcongenitalheartdisease 150417031927-conversion-gate01
Acyanoticcongenitalheartdisease 150417031927-conversion-gate01Acyanoticcongenitalheartdisease 150417031927-conversion-gate01
Acyanoticcongenitalheartdisease 150417031927-conversion-gate01
 
Congenital heart disease
Congenital heart disease Congenital heart disease
Congenital heart disease
 
Congenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - RivinCongenital Heart Diseases in Newborns - Rivin
Congenital Heart Diseases in Newborns - Rivin
 
Timing of Interventions in Acyanotic CHD
Timing of Interventions in Acyanotic CHDTiming of Interventions in Acyanotic CHD
Timing of Interventions in Acyanotic CHD
 

Más de Irving Torres Lopez

NOBLE LEFT MAIN BIFURCATION PCI (1).pptx
NOBLE LEFT MAIN BIFURCATION PCI (1).pptxNOBLE LEFT MAIN BIFURCATION PCI (1).pptx
NOBLE LEFT MAIN BIFURCATION PCI (1).pptxIrving Torres Lopez
 
APPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptx
APPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptxAPPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptx
APPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptxIrving Torres Lopez
 
6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf
6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf
6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdfIrving Torres Lopez
 
NOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptxNOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptxIrving Torres Lopez
 
ARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdf
ARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdfARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdf
ARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdfIrving Torres Lopez
 
VASOPRESORES E INOTRÓPICOS CLASE EXPO.pptx
VASOPRESORES E INOTRÓPICOS CLASE EXPO.pptxVASOPRESORES E INOTRÓPICOS CLASE EXPO.pptx
VASOPRESORES E INOTRÓPICOS CLASE EXPO.pptxIrving Torres Lopez
 
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdfClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdfIrving Torres Lopez
 

Más de Irving Torres Lopez (13)

NOBLE LEFT MAIN BIFURCATION PCI (1).pptx
NOBLE LEFT MAIN BIFURCATION PCI (1).pptxNOBLE LEFT MAIN BIFURCATION PCI (1).pptx
NOBLE LEFT MAIN BIFURCATION PCI (1).pptx
 
APPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptx
APPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptxAPPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptx
APPROACH TO CORONARY BIFURCATION LESIONS-DR SANTHOSH 2 (1).pptx
 
2023_evaluacion_CP.doc
2023_evaluacion_CP.doc2023_evaluacion_CP.doc
2023_evaluacion_CP.doc
 
6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf
6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf
6d13ad17-73dc-4a10-9b7b-f5e806dcdf2f.pdf
 
NOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptxNOBLE LEFT MAIN BIFURCATION PCI.pptx
NOBLE LEFT MAIN BIFURCATION PCI.pptx
 
3-cardiology-hemodynamics.ppt
3-cardiology-hemodynamics.ppt3-cardiology-hemodynamics.ppt
3-cardiology-hemodynamics.ppt
 
ARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdf
ARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdfARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdf
ARCH 2019 wires and balloons.pptx FINAL.MAC_.4x3v1.pdf
 
VASOPRESORES E INOTRÓPICOS CLASE EXPO.pptx
VASOPRESORES E INOTRÓPICOS CLASE EXPO.pptxVASOPRESORES E INOTRÓPICOS CLASE EXPO.pptx
VASOPRESORES E INOTRÓPICOS CLASE EXPO.pptx
 
guidecatheters-220309051744.pdf
guidecatheters-220309051744.pdfguidecatheters-220309051744.pdf
guidecatheters-220309051744.pdf
 
optimize guide support.pptx
optimize guide support.pptxoptimize guide support.pptx
optimize guide support.pptx
 
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdfClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
ClinicalOutcomesFollowingCoronary BifurcationPCITechniques.pdf
 
050408.pdf
050408.pdf050408.pdf
050408.pdf
 
EUROVALVE-2018.pdf
EUROVALVE-2018.pdfEUROVALVE-2018.pdf
EUROVALVE-2018.pdf
 

Último

WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebUiPathCommunity
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .Alan Dix
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr BaganFwdays
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxLoriGlavin3
 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Manik S Magar
 
unit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptxunit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptxBkGupta21
 
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024BookNet Canada
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Commit University
 
A Journey Into the Emotions of Software Developers
A Journey Into the Emotions of Software DevelopersA Journey Into the Emotions of Software Developers
A Journey Into the Emotions of Software DevelopersNicole Novielli
 
Time Series Foundation Models - current state and future directions
Time Series Foundation Models - current state and future directionsTime Series Foundation Models - current state and future directions
Time Series Foundation Models - current state and future directionsNathaniel Shimoni
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxhariprasad279825
 
What is Artificial Intelligence?????????
What is Artificial Intelligence?????????What is Artificial Intelligence?????????
What is Artificial Intelligence?????????blackmambaettijean
 
What is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfWhat is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfMounikaPolabathina
 

Último (20)

WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio Web
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!
 
unit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptxunit 4 immunoblotting technique complete.pptx
unit 4 immunoblotting technique complete.pptx
 
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!
 
A Journey Into the Emotions of Software Developers
A Journey Into the Emotions of Software DevelopersA Journey Into the Emotions of Software Developers
A Journey Into the Emotions of Software Developers
 
Time Series Foundation Models - current state and future directions
Time Series Foundation Models - current state and future directionsTime Series Foundation Models - current state and future directions
Time Series Foundation Models - current state and future directions
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptx
 
What is Artificial Intelligence?????????
What is Artificial Intelligence?????????What is Artificial Intelligence?????????
What is Artificial Intelligence?????????
 
What is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdfWhat is DBT - The Ultimate Data Build Tool.pdf
What is DBT - The Ultimate Data Build Tool.pdf
 

atrialseptaldefect-170725142325.pdf

  • 1. ATRIAL SEPTAL DEFECT (ASD) Presenter Dr. Maimuna Sayeed Resident (Phase A) Paediatric Gastroenterology & Nutrition
  • 2. Introduction Atrial septal defect (ASD) is an abnormal communication between the atria due to a defect in the interatrial septum.
  • 3. Incidence • ASDs constitute 8% to 10% of congenital heart defects in children. • The recent incidence of ASDs has been estimated to be 100 per 100,000 live births. • The female:male ratio for secundum ASDs is 2:1, but for the sinus venosus ASDs it is 1:1 . Moss and Adams’ Heart disease in infants, children and adolescents, 9th edition
  • 4. Incidence About 30% to 50% of children with congenital heart defects have an ASD as part of the cardiac defect. Park’s Pediatric Cardiology for Practitioners, 6th edition
  • 5. Epidemiology The majority of cases of ASD are sporadic. Autosomal dominant inheritance does occur as part of the • Holt-Oram syndrome (hypoplastic or absent thumbs, radii, triphalangism, phocomelia, 1st-degree heart block, ASD) or in • families with secundum ASD and heart block. Nelson Textbook of Pediatrics, 20th edition
  • 7.
  • 8. Types of ASD 1. Secundum ASD (75%) 2. Ostium primum ASD (20%) 3. Sinus venosus ASD (5%) 4. Coronary sinus ASD (<1%) Moss and Adams’ Heart disease in infants, children and adolescents, 9th edition
  • 9. Secundum ASDs Location: • This defect is present at the site of fossa ovalis. • Secundum ASDs may be single or multiple (fenestrated atrial septum).
  • 10. Secundum ASDs (cont) Associations: • Partial anomalous pulmonary venous return • Pulmonary valvular stenosis • VSD • Pulmonary artery branch stenosis • Persistent left superior vena cava • Mitral valve prolapse and insufficiency • Holt-Oram syndrome
  • 11. Ostium primum ASD Location: • In the lower portion of the atrial septum and overlies the mitral and tricuspid valves.
  • 12. Ostium primum ASD (cont) Associations: Isolated ostium primum ASD occurs in about 15% of all ASDs. Other defects include- • Ostium primum defects with clefts in the anterior mitral and septal tricuspid valve leaflets and • Small ventricular septal defects.
  • 13. Sinus venosus ASD Location: • It is most commonly located at the entry of the SVC into the RA (superior vena caval type) and • rarely at the entry of the IVC into the RA (inferior vena caval type).
  • 14. Sinus venosus ASD (cont) Associations: • The superior vena caval type is very commonly associated with anomalous drainage of the right upper pulmonary vein (into the RA), and • The inferior vena caval type is often associated with anomalous drainage of the right lung into the IVC (“scimitar syndrome”)
  • 15. Coronary sinus ASD Location: • There is a defect in the roof of the coronary sinus, resulting in direct communication with the left atrium. Types: • Complete unroofing of the CS • Partial unroofing of the CS Associations: • Commonly with a persistent left SVC.
  • 16. Pathophysiology of ASD The degree of left to right shunting is dependent on: • the size of the defect • the relative compliance of the right ventricle and left ventricle and • the relative vascular resistance in the pulmonary and systemic circulations.
  • 17. Pathophysiology (cont) In moderate-to-large defects, a considerable shunt of oxygenated blood flows from the left to the right atrium ↓ Volume overload and dilation of the right atrium and ventricle ↓ The tricuspid and pulmonary annuli may dilate and become incompetent ↓ Increased flow into the lungs ↓ Pulmonary arteries, capillaries & the veins are dilated
  • 18. Pathophysiology (cont) Pulmonary arteries, capillaries & the veins are dilated ↓ Flow-related pulmonary artery hypertension ↓ Medial hypertrophy of pulmonary arteries and muscularization of the arterioles resulting in pulmonary vascular obstructive disease ↓ Reversal of the shunt ↓ Eisenmenger syndrome
  • 20. History  Asymptomatic  Infants • features of pulmonary overcirculation • recurrent respiratory infections • failure to thrive  Older children • mild fatigue • dyspnea that may worsen with age
  • 21. Physical Examination Examination of precordium Inspection: Left precordial bulge. Palpation: Prominent right ventricular impulse felt along the lower left sternal border and the subcostal area.
  • 22. Physical Examination (cont) Auscultation: • Wide, fixed splitting of the second heart sound (S2). • A systolic ejection murmur best heard at the left upper sternal border. • A short, rumbling mid-diastolic murmur is often audible at the lower left sternal border.
  • 24. Investigations • Chest X-RAY • ECG • Echocardiography • Cardiac catheterization (occasionally)
  • 25. Chest X-Ray A small shunt across the ASD • normal-appearing CXR Patients with significant shunts • Cardiomegaly, due to right atrial and right ventricular enlargement, and • Increased pulmonary vascular markings extending to the periphery. • A prominent pulmonary artery (PA) segment.
  • 26. Electrocardiogram A small left-to-right shunt and no right atrial or ventricular dilation, the ECG is normal. Secundum ASD A significant left-to-right shunt • Right axis deviation • Right ventricular hypertrophy • rsR′ pattern in V1
  • 27. Electrocardiogram (cont) Ostium Primum ASD • Left axis deviation
  • 28. Echocardiography Two-dimensional echo study is diagnostic. It shows • the position as well as the size of the defect. • the enlarged right atrium, right ventricle, and pulmonary arteries. • associated anomalies such as pulmonary stenosis, mitral valve prolapse, and anomalous pulmonary venous return.
  • 29. Echocardiography (cont) Color Doppler can visualize the shunt across the ASD. • A qualitative assessment of the shunt across the ASD is done by direct visualization of the shunt and its effect on the right- sided cardiac chambers. • A quantitative assessment of the pulmonary to systemic blood flow ratio (Qp: Qs) also can be made.
  • 30. Echocardiography (cont) Pulsed Doppler examination reveals a characteristic flow pattern with the maximum left-to-right shunt occurring in diastole.
  • 31. Echocardiography (cont) Transesophageal echocardiography (TEE) • may be used as an alternative for older children and adolescents, especially in those who are overweight. • used to detect a sinus venosus ASD. • is a monitoring adjunct for operative and per- cutaneous closure of ASD.
  • 32. Echocardiography (cont) Three-Dimensional Echocardiography • allows better morphologic delineation of the ASD and its surrounding structures. • used for guiding device closure during the procedure.
  • 33. Cardiac Catheterization Indicated • If pulmonary vascular disease is suspected. • Diagnosing associated lesions such as partial anomalous pulmonary venous return or mitral stenosis. • Direct measurement of intracardiac and pulmonary artery pressure can be performed. • Pulmonary vascular resistance can be calculated.
  • 35. Medical 1. Exercise restriction is unnecessary. 2. Asymptomatic infant and children are followed up at yearly interval until surgery is recommended prior to school entry. 3. Symptomatic, anti-congestive therapy with diuretics may be indicated until closure is accomplished.
  • 36. Management (cont) Closure of an ASD is indicated if there is a large shunt. Indicators of a large shunt include • Qp:Qs ≥ 1.5. • A diastolic flow rumble in the tricuspid area, • ECG evidence of right ventricular hypertrophy, • Chest x-ray evidence of cardiomegaly or increased pulmonary vascular markings, or • Echocardiographic evidence of right ventricular enlargement and/or paradoxical septal motion.
  • 37. Nonsurgical Closure • Several closure devices that can be delivered through cardiac catheters have been shown to be safe and efficacious for secundum ASD closure. • Currently there is no transcatheter devices designed for closer of sinus venosus, primum or coronary sinus ASD.
  • 38. Nonsurgical Closure Devices available for clinical use: A. Amplatzer septal occlude B. Gore Helix septal occlude C. CardioSEAL device D. BioSTAR device
  • 40. Nonsurgical Closure Indications • Secundum ASD, measuring 5 mm or more in diameter (but less than 32 mm). • A significant left-to-right shunt with clinical evidence of right ventricular volume overload (i.e., Qp/Qs ratio of 1.5:1 or greater or RV enlargement). • There must be enough rim (4 mm) of septal tissue around the defect for appropriate placement of the device.
  • 41. Nonsurgical Closure Advantages • Complete avoidance of cardiopulmonary bypass. • Avoidance of pain and residual thoracotomy scars. • A less than 24-hour hospital stay, and rapid recovery.
  • 42. Nonsurgical Closure Post-device closure follow-up: The patients are administered aspirin 5 mg/kg/day for 6 months. Post procedure echo studies check for • a residual atrial shunt and • unobstructed flow of pulmonary veins, coronary sinus, and venae cavae and • proper function of the mitral and tricuspid valves.
  • 43. Surgical Closure Indications and Timing • A left-to-right shunt with a pulmonary-to-systemic blood flow ratio ( Qp/ Qs) of ≥1.5:1 only if device closure is not considered appropriate. • If CHF does not respond to medical management, surgery is performed during infancy, again if device closure is considered inappropriate. • If oxygen and other medical therapy are needed for infants with associated bronchopulmonary dysplasia and the device closure is not considered appropriate, surgery is performed during infancy. • ASD with other associations
  • 46. Surgical Closure Complications: • Cerebrovascular accident and • Postoperative arrhythmias
  • 47. Surgical Closure Postoperative Follow-up • Cardiomegaly on x-ray film and enlarged RV dimension on echo as well as the wide splitting of the S2 may persist for 1 or 2 years postoperatively. The ECG typically demonstrates RBBB (or RV conduction disturbance). • Atrial or nodal arrhythmias occur in 7% to 20% of postoperative patients. Occasionally, sick sinus syndrome, which occurs especially after the repair of a sinus venosus defect, may require antiarrhythmic drugs, pacemaker therapy, or both. • Rarely, patients with residual shunt may be administered aspirin to prevent paradoxical embolization.
  • 48. Natural History of ASDs • In patients with an ASD less than 3 mm in size diagnosed before 3 months of age, spontaneous closure occurs in 100% of patients at 1½ years of age. • Spontaneous closure occurs more than 80% in patients with defects between 3 and 8 mm before 1½ years of age. • An ASD with a diameter greater than 8 mm rarely closes spontaneously.
  • 49. Natural History of ASDs • Most children with an ASD remain active and asymptomatic. Rarely, congestive heart failure (CHF) can develop in infancy. • If a large defect is untreated, CHF and pulmonary hypertension develop in adults who are in their 20s and 30s. • With or without surgery, atrial arrhythmias (flutter or fibrillation) may occur in adults. • Infective endocarditis does not occur in patients with isolated ASDs. • Cerebrovascular accident, resulting from paradoxical embolization through an ASD, is a rare complication.